Back to top

Stoke Therapeutics appoints McCauley as Chief Scientific Officer

Stoke Therapeutics (STOK) announced that Thomas McCauley, Ph.D., has been appointed Chief Scientific Officer. McCauley most recently served as the ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Stoke Therapeutics, Inc. (STOK)